Prenuvo and UT Dallas researchers found links between sleep efficiency, visceral fat and brain volume, with long sleepers ...

Mission Therapeutics has begun a 36-patient Phase 1b study of MTX325, a drug aimed at clearing out damaged mitochondria in ...

A Biograph study using AI on routine heart CT scans found inflammation that cholesterol tests and risk calculators could not ...

United Therapeutics will test treprostinil SMI in about 40 patients with pulmonary hypertension linked to COPD.

Arrowhead says its RNAi drug crossed the blood-brain barrier in healthy volunteers and sharply lowered tau, a protein tied to ...

Swiss fertility heavyweight bets on stem-cell-derived egg maturation – and on ovarian biology as a market worth owning.

The Boston company says the deal more than doubles its patient reach and opens a path to brain-based sleep testing in primary ...

Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and ...

Fitnescity Health opens its 1,000-plus imaging locations to digital health platforms through one API, with Superpower on ...

XellSmart’s off-the-shelf XS411 lifted motor scores in nine patients, and its 30-person Phase II trial has finished enrolling ...

German biotech MODAG won for pairing a CE-marked diagnostic with a drug candidate that targets the same protein.

As pharma shops for de-risked science, venture money is moving later and concentrating in fewer, bigger bets – our report ...